Evaluating the Impact of the New CKD-EPI Creatinine Equation (2021) for eGFR on the Management of Muscle Invasive Bladder Cancer
Abstract
The estimated glomerular filtration rate (eGFR) equation had been historically calculated inclusive of a race coefficient. However, in September 2021, the NKF and the American Society of Nephrology Task Force announced a new race-free calculation for eGFR due to criticism around racial disparities. Aspects of treatment decisions for muscle-invasive bladder cancer (MIBC) such as cisplatin-based neoadjuvant chemotherapy (NAC) eligibility depend on eGFR due to potential nephrotoxic effects.Description
Presented at the American Urological Association Annual Conference. May 6, 2024 and APPNA's 47th Annual Conference, July 6, 2024.Rights/Terms
Attribution-NonCommercial-NoDerivatives 4.0 InternationalIdentifier to cite or link to this item
http://hdl.handle.net/10713/22105Collections
The following license files are associated with this item:
- Creative Commons
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 International